Targeting the ERβ/HER Oncogenic Network in <i>KRAS</i> Mutant Lung Cancer Modulates the Tumor Microenvironment and Is Synergistic with Sequential Immunotherapy.

F+D slightly increased CD206+ macrophages in spleens but it did not reach statistical significance, and also did not change the proportion of M2+ macrophages in tumors, which was considerably elevated in the placebo condition at the time of tumor harvest (97% of total macrophages).

also in 111,027 other papers